Otto Sussmann

机构：Caucaseco Scientific Research Center, Asociación Colombiana de Infectología

发表论文 35 篇 · 总被引 605 次 · h-index 10

代表论文

• Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate is Non-inferior to Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-naive Adults With Human Immunodeficiency Virus–1 Infection: Week 48 Results of the DRIVE-AHEAD Trial (2018 · Clinical Infectious Diseases · 被引 174)
• Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (TDF) Versus Efavirenz/Emtricitabine/TDF in Treatment-naive Adults With Human Immunodeficiency Virus Type 1 Infection: Week 96 Results of the Randomized, Double-blind, Phase 3 DRIVE-AHEAD Noninferiority Trial (2020 · Clinical Infectious Diseases · 被引 80)
• Association of HIV status with infection by multiple HPV types (2018 · Tropical Medicine & International Health · 被引 35)
• Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial (2017 · The Lancet HIV · 被引 35)
• Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials (2023 · The Lancet HIV · 被引 34)
• Human papillomavirus detection in women with and without human immunodeficiency virus infection in Colombia (2014 · BMC Cancer · 被引 24)